Profile data is unavailable for this security.
About the company
Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.
- Revenue in USD (TTM)129.33m
- Net income in USD-39.71m
- Incorporated2007
- Employees441.00
- LocationQuanterix Corp900 Middlesex TurnpikeBILLERICA 01821United StatesUSA
- Phone+1 (617) 301-9400
- Fax+1 (302) 655-5049
- Websitehttps://www.quanterix.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MaxCyte Inc | 45.44m | -35.43m | 431.20m | 143.00 | -- | 1.94 | -- | 9.49 | -0.3408 | -0.3408 | 0.437 | 2.11 | 0.1739 | 0.4741 | 7.46 | 317,762.90 | -13.56 | -13.18 | -14.25 | -14.33 | 88.43 | 88.79 | -77.97 | -62.96 | 13.40 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
| Varex Imaging Corp | 832.70m | 34.20m | 441.31m | 2.30k | 23.59 | 0.7586 | 6.49 | 0.530 | 0.4574 | 0.4574 | 16.46 | 14.22 | 0.6758 | 1.95 | 5.28 | 346,958.30 | 2.82 | 0.9913 | 3.33 | 1.18 | 32.16 | 31.70 | 4.17 | 1.36 | 1.89 | 2.00 | 0.4271 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
| ZimVie Inc | 453.38m | -54.86m | 456.31m | 2.60k | -- | 1.16 | -- | 1.01 | -2.04 | -13.27 | 16.84 | 14.29 | 0.3858 | 1.12 | 3.80 | 174,378.50 | -4.67 | -- | -5.43 | -- | 63.11 | 65.51 | -12.10 | -8.73 | 1.43 | -0.3884 | 0.3737 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| Pacific Biosciences of California Inc | 188.87m | -400.38m | 497.37m | 796.00 | -- | 1.01 | -- | 2.63 | -1.50 | -1.50 | 0.7099 | 1.81 | 0.1125 | 2.05 | 6.69 | 237,275.10 | -23.85 | -16.19 | -26.63 | -17.81 | 26.01 | 37.35 | -211.99 | -136.21 | 7.14 | -22.46 | 0.6444 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Surmodics Inc | 120.82m | -1.40m | 555.73m | 376.00 | -- | 4.74 | 75.99 | 4.60 | -0.0955 | -0.0955 | 8.55 | 8.28 | 0.6597 | 2.09 | 5.64 | 321,332.40 | -0.7638 | -1.85 | -0.8909 | -2.18 | 74.02 | 82.93 | -1.16 | -2.98 | 3.22 | -4.46 | 0.1999 | -- | 32.65 | 10.27 | 94.37 | -- | -27.02 | -- |
| Quanterix Corp | 129.33m | -39.71m | 558.03m | 441.00 | -- | 1.66 | -- | 4.31 | -1.04 | -1.04 | 3.40 | 8.77 | 0.3078 | 2.37 | 4.60 | 293,265.30 | -9.45 | -15.96 | -10.30 | -17.66 | 57.42 | 52.79 | -30.71 | -53.79 | 8.99 | -- | 0.00 | -- | 15.96 | 26.60 | 66.56 | -- | 20.07 | -- |
| Paragon 28 Inc | 235.44m | -59.07m | 573.67m | 430.00 | -- | 3.91 | -- | 2.44 | -0.7132 | -0.7132 | 2.84 | 1.76 | 0.7703 | 0.6049 | 6.63 | 547,539.60 | -19.33 | -- | -23.48 | -- | 76.67 | -- | -25.09 | -- | 1.70 | -5.30 | 0.4295 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| Iradimed Corp | 69.48m | 18.64m | 607.90m | 148.00 | 32.80 | 7.63 | 31.23 | 8.75 | 1.46 | 1.46 | 5.45 | 6.29 | 0.8109 | 1.55 | 6.03 | 469,485.30 | 21.76 | 13.16 | 23.85 | 14.58 | 77.21 | 76.55 | 26.83 | 21.46 | 8.25 | 144.05 | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| Orthofix Medical Inc | 771.65m | -120.49m | 608.35m | 1.63k | -- | 1.13 | -- | 0.7884 | -3.21 | -3.21 | 20.55 | 14.35 | 0.8654 | 1.17 | 6.49 | 472,245.40 | -13.51 | -8.88 | -16.22 | -10.96 | 67.18 | 72.37 | -15.62 | -9.28 | 1.13 | -4.94 | 0.2005 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| AxoGen Inc | 173.48m | -16.54m | 617.12m | 426.00 | -- | 6.45 | -- | 3.56 | -0.3829 | -0.3829 | 4.01 | 2.18 | 0.9117 | 1.62 | 7.43 | 407,237.10 | -8.69 | -13.92 | -9.93 | -15.84 | 76.98 | 79.74 | -9.53 | -20.28 | 2.32 | -2.94 | 0.3297 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Simulations Plus Inc | 66.98m | 9.65m | 624.84m | 192.00 | 65.88 | 3.45 | 44.19 | 9.33 | 0.474 | 0.474 | 3.29 | 9.04 | 0.3603 | -- | 5.57 | 348,843.80 | 5.19 | 7.20 | 5.49 | 7.61 | 72.53 | 77.61 | 14.40 | 21.29 | -- | -- | 0.00 | 45.70 | 10.52 | 14.96 | -20.20 | 6.02 | 12.91 | 0.8548 |
| Jin Medical International Ltd | 20.13m | 2.91m | 638.71m | 245.00 | 218.88 | 24.34 | 209.57 | 31.74 | 0.0186 | 0.0186 | 0.1292 | 0.1676 | 0.5576 | 2.38 | 4.22 | 82,143.59 | 7.80 | 12.81 | 11.27 | 20.92 | 34.73 | 33.58 | 13.99 | 14.60 | 2.27 | -- | 0.2702 | 0.00 | 3.29 | -1.07 | 6.34 | -4.80 | -9.50 | -- |
| SI-Bone Inc | 150.71m | -40.85m | 641.67m | 344.00 | -- | 3.88 | -- | 4.26 | -1.00 | -1.00 | 3.70 | 3.97 | 0.6586 | 1.54 | 6.67 | 438,107.60 | -17.85 | -27.88 | -19.57 | -30.94 | 77.69 | 85.03 | -27.10 | -51.09 | 8.12 | -- | 0.18 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Cytek Biosciences Inc | 197.71m | -17.56m | 669.36m | 645.00 | -- | 1.72 | -- | 3.39 | -0.1327 | -0.1327 | 1.49 | 2.96 | 0.392 | 1.54 | 4.19 | 292,470.40 | -3.48 | -- | -3.89 | -- | 54.97 | -- | -8.88 | -- | 6.38 | -- | 0.0083 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| Mesa Laboratories Inc | 223.71m | -250.31m | 695.46m | 736.00 | -- | 4.61 | -- | 3.11 | -46.43 | -46.43 | 41.43 | 27.87 | 0.4131 | 2.51 | 6.29 | 303,956.50 | -46.23 | -9.20 | -50.62 | -9.88 | 62.27 | 60.60 | -111.89 | -28.33 | 1.37 | 1.33 | 0.5848 | -- | -1.32 | 15.95 | -27,438.28 | -- | 15.26 | 0.00 |
| Orthopediatrics Corp | 175.07m | -25.12m | 695.92m | 247.00 | -- | 1.87 | -- | 3.98 | -1.10 | -1.10 | 7.65 | 15.33 | 0.4045 | 0.4286 | 4.61 | 708,793.50 | -5.80 | -5.40 | -6.43 | -5.93 | 74.62 | 75.09 | -14.35 | -15.92 | 1.96 | -44.23 | 0.0261 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
Data as of Sep 20 2024. Currency figures normalised to Quanterix Corp's reporting currency: US Dollar USD
41.41%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| AllianceBernstein LPas of 30 Jun 2024 | 3.41m | 8.90% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 2.73m | 7.10% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 1.98m | 5.17% |
| Portolan Capital Management LLCas of 30 Jun 2024 | 1.92m | 5.00% |
| Threadneedle Asset Management Ltd.as of 30 Jun 2024 | 1.30m | 3.38% |
| Granahan Investment Management, LLCas of 30 Jun 2024 | 1.13m | 2.94% |
| Gilder, Gagnon, Howe & Co. LLCas of 30 Jun 2024 | 932.80k | 2.43% |
| Geode Capital Management LLCas of 30 Jun 2024 | 840.44k | 2.19% |
| Millennium Management LLCas of 30 Jun 2024 | 834.85k | 2.18% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 818.39k | 2.13% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
